K-ras mutations in nonmucinous ovarian epithelial tumors: A molecular analysis and clinicopathologic study of 144 patients

Cancer

Volumn 82, Issue 6, 1998, Pages 1088-1095

  Cuatrecasas, Miriam ^a   Erill, Nadina ^a   Musulen, Eva ^a   Costa, Irmgard ^a   Matias Guiu, Xavier ^a   Prat, Jaime ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

K ras; Nonmucinous tumors; Oncocgenes; Ovary; Point mutation; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BRENNER TUMOR; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE K RAS; OVARY CARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CODON; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0032520776     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980315)82:6<1088::AID-CNCR12>3.0.CO;2-2     Document Type: Article

References (27)

1. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumours. International histological classification of tumours, No. 9. Geneva: World Health Organization, 1973.
2. Morrow CP. Malignant and borderline epithelial tumors of the ovary: clinical features, staging, diagnosis, intraoperative assessment and review of management. In: Coppleson M. editor. Gynecologic oncology. Edinburgh: Churchill Livingstone, 1992:888-915.
3. Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of the ovary. In: Coppleson M. Gynecologic oncology. Edinburgh: Churchill Livingstone, 1992:863-87.
4. Ozols RF, Rubin SC, Dembo AJ, Robboy SJ. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC. Principles and practice of gynecologic oncology. Philadelphia: J. B. Lippincott, 1992:731-81.
5. Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, et al. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinomas. Gynecol Oncol 1992;47:53-7.
6. Whetsell L, Maw G, Nadon N, Ringer DP, Schaefer FV. Polymerase chain reaction microanalysis of tumors from stained histological slides. Oncogene 1992;7:2355-61.
7. Mies C, Houldsworth J, Chaganti RSK. Extraction of DNA from paraffin blocks for Southern blot analysis. Am J Surg Pathol 1991;15:169-74.
8. Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei: a clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol 1996;20:739-46.
9. Nakano H, Yamamoto F, Neville C, Evans D, Mizuno T, Perucho M. Isolation of transforming sequences in two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. Proc Natl Acad Sci USA 1984; 81:71-5.
10. Kumar R, Barbacid M. Oncogene detection at the single cell level. Oncogene 1988;3:647-51.
11. Jiang W, Kahn SM, Guillem JG, Lu SH, Weinstein IB. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal and gastric cancer. Oncogene 1989;4: 923-8.
12. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J. K-ras mutations in ovarian mucinous tumors: a clinico-pathologic and molecular study of 95 cases. Cancer 1997;79:1581-6.
13. Mc Cormick F. ras oncogenes. In: Winberg R. Oncogenes and the molecular origins of cancer. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989:125-45.
14. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
15. Kumar R, Sukumar S, Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science 1990;248: 1101-4.
16. Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1994;14: 237-44.
17. Vogelstein B, Fearon E, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
18. Piretti M, Cavalieri C, Conway PS, Gallion HN, Powell DE, Tuker MS. Genetic alterations distinguish different types of ovarian tumors. Int J Cancer 1995;64:434-40.
19. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 1993;53:3103-8.
20. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rece J. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1989;139:777-85.
21. Berchuck A, Kohler MF, Bast RC. Oncogenes in ovarian cancer. Hematol Oncol Clin North Am 1992;6:813-25.
22. Boltz E, Kefford R, Leary J. Amplification of c-Ki-ras oncogene in human ovarian tumors. Int J Cancer 1989;43:428-30.
23. Smith DM, Groff DE, Potkul RK, Bear JL, Delgado G. Determination of cellular oncogene rearrangement of amplification in ovarian adenocarcinomas. Am J Obstet Gynecol 1989;161:911-5.
24. van't Veer L, Hermens R, van den Berg-Baker L. ras oncogene activation in human ovarian carcinoma. Oncogene 1988;2:157-65.
25. Fukomoto M, Estensen R, Sha I. Association of K-ras with amplified DNA sequences detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res 1989;49:1693-7.
26. Zhou D, Gonzalez-Cadaviv N, Ahuja H, Battifora H, Moore GE, Cline MJ. A unique pattern of proto-oncogene abnormalities on ovarian adenocarcinomas. Cancer 1988;62:1573-6.
27. Mok SCH, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, et al. Mutation of K-ras proto-oncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993;53:1489-92.